Correlation Between Entrada Therapeutics and Hillcrest Energy

Can any of the company-specific risk be diversified away by investing in both Entrada Therapeutics and Hillcrest Energy at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entrada Therapeutics and Hillcrest Energy into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Entrada Therapeutics and Hillcrest Energy Technologies, you can compare the effects of market volatilities on Entrada Therapeutics and Hillcrest Energy and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entrada Therapeutics with a short position of Hillcrest Energy. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entrada Therapeutics and Hillcrest Energy.

Diversification Opportunities for Entrada Therapeutics and Hillcrest Energy

-0.51

Correlation Coefficient

Entrada Therapeutics  Hillcrest Energy

Excellent diversification

The 3 months correlation between Entrada and Hillcrest is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Entrada Therapeutics and Hillcrest Energy Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hillcrest Energy Tec and Entrada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entrada Therapeutics are associated (or correlated) with Hillcrest Energy. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hillcrest Energy Tec has no effect on the direction of Entrada Therapeutics i.e., Entrada Therapeutics and Hillcrest Energy go up and down completely randomly.

Pair Corralation between Entrada Therapeutics and Hillcrest Energy

Given the investment horizon of 90 days Entrada Therapeutics is expected to generate 0.41 times more return on investment than Hillcrest Energy. However, Entrada Therapeutics is 2.43 times less risky than Hillcrest Energy. It trades about 0.06 of its potential returns per unit of risk. Hillcrest Energy Technologies is currently generating about -0.16 per unit of risk. If you would invest  1,645  in Entrada Therapeutics on September 27, 2024 and sell it today you would earn a total of  133.00  from holding Entrada Therapeutics or generate 8.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

Entrada Therapeutics  vs.  Hillcrest Energy Technologies

Entrada Therapeutics

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Entrada Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Entrada Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Hillcrest Energy Tec

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hillcrest Energy Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Entrada Therapeutics and Hillcrest Energy

The main advantage of trading using opposite Entrada Therapeutics and Hillcrest Energy positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entrada Therapeutics position performs unexpectedly, Hillcrest Energy can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hillcrest Energy will offset losses from the drop in Hillcrest Energy's long position.

The idea behind Entrada Therapeutics and Hillcrest Energy Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.